Ahmed S, Aschner M, Alsharif K, Allahyani M, Huang G, Wan C
Naunyn Schmiedebergs Arch Pharmacol. 2025; .
PMID: 39992419
DOI: 10.1007/s00210-025-03901-w.
Serafin P, Kleczkowska P
Pharmaceutics. 2023; 15(11).
PMID: 38004575
PMC: 10674911.
DOI: 10.3390/pharmaceutics15112597.
Lee Y, Shirkey J, Park J, Bisht K, Cowan A
Biodes Res. 2023; 2022:9898241.
PMID: 37850133
PMC: 10521750.
DOI: 10.34133/2022/9898241.
Li S, Li Y, Liu Y, Wu Y, Wang Q, Jin L
Int J Mol Sci. 2023; 24(10).
PMID: 37239989
PMC: 10218668.
DOI: 10.3390/ijms24108642.
Karthik Y, Kalyani M, Krishnappa S, Devappa R, Anjali Goud C, Ramakrishna K
Front Microbiol. 2023; 14:1096826.
PMID: 36876075
PMC: 9982118.
DOI: 10.3389/fmicb.2023.1096826.
Anti-Cancer Peptides: Status and Future Prospects.
Ghaly G, Tallima H, Dabbish E, ElDin N, Abd El-Rahman M, Ibrahim M
Molecules. 2023; 28(3).
PMID: 36770815
PMC: 9920184.
DOI: 10.3390/molecules28031148.
Activity and Synergy of Cu-ATCUN Antimicrobial Peptides.
Greve J, Cowan J
Int J Mol Sci. 2022; 23(22).
PMID: 36430622
PMC: 9692552.
DOI: 10.3390/ijms232214151.
Single-step green synthesis of gold conjugated polyphenol nanoparticle using extracts of Saudi's myrrh: Their characterization, molecular docking and essential biological applications.
Al-Radadi N
Saudi Pharm J. 2022; 30(9):1215-1242.
PMID: 36249941
PMC: 9562988.
DOI: 10.1016/j.jsps.2022.06.028.
Peptide therapeutics in the management of metastatic cancers.
Bose D, Roy L, Chatterjee S
RSC Adv. 2022; 12(33):21353-21373.
PMID: 35975072
PMC: 9345020.
DOI: 10.1039/d2ra02062a.
Repositioning of experimentally validated anti-breast cancer peptides to target FAK-PAX complex to halt the breast cancer progression: a biomolecular simulation approach.
Khan A, Shan S, Toor T, Suleman M, Wang Y, Zhou J
Mol Divers. 2022; 27(2):603-618.
PMID: 35635599
DOI: 10.1007/s11030-022-10438-0.
Elastic moduli of normal and cancer cell membranes revealed by molecular dynamics simulations.
Nguyen H, Man V, Li M, Derreumaux P, Wang J, Nguyen P
Phys Chem Chem Phys. 2022; 24(10):6225-6237.
PMID: 35229839
PMC: 8988946.
DOI: 10.1039/d1cp04836h.
Revealing the Mechanisms of Synergistic Action of Two Magainin Antimicrobial Peptides.
Bechinger B, Juhl D, Glattard E, Aisenbrey C
Front Med Technol. 2022; 2:615494.
PMID: 35047895
PMC: 8757784.
DOI: 10.3389/fmedt.2020.615494.
Membrane-disruptive peptides/peptidomimetics-based therapeutics: Promising systems to combat bacteria and cancer in the drug-resistant era.
Lin L, Chi J, Yan Y, Luo R, Feng X, Zheng Y
Acta Pharm Sin B. 2021; 11(9):2609-2644.
PMID: 34589385
PMC: 8463292.
DOI: 10.1016/j.apsb.2021.07.014.
The Spectrum of Design Solutions for Improving the Activity-Selectivity Product of Peptide Antibiotics against Multidrug-Resistant Bacteria and Prostate Cancer PC-3 Cells.
Juretic D, Golemac A, Strand D, Chung K, Ilic N, Goic-Barisic I
Molecules. 2020; 25(15).
PMID: 32752241
PMC: 7436000.
DOI: 10.3390/molecules25153526.
Temporin A and Bombinin H2 Antimicrobial Peptides Exhibit Selective Cytotoxicity to Lung Cancer Cells.
Swithenbank L, Cox P, Harris L, Dudley E, Sinclair K, Lewis P
Scientifica (Cairo). 2020; 2020:3526286.
PMID: 32676212
PMC: 7341413.
DOI: 10.1155/2020/3526286.
Bioactive Peptides: Synthesis, Properties, and Applications in the Packaging and Preservation of Food.
Perez Espitia P, Soares N, Dos Reis Coimbra J, Andrade N, Souza Cruz R, Alves Medeiros E
Compr Rev Food Sci Food Saf. 2020; 11(2):187-204.
PMID: 32368201
PMC: 7194098.
DOI: 10.1111/j.1541-4337.2011.00179.x.
ACPred: A Computational Tool for the Prediction and Analysis of Anticancer Peptides.
Schaduangrat N, Nantasenamat C, Prachayasittikul V, Shoombuatong W
Molecules. 2019; 24(10).
PMID: 31121946
PMC: 6571645.
DOI: 10.3390/molecules24101973.
Biophysical Investigations Elucidating the Mechanisms of Action of Antimicrobial Peptides and Their Synergism.
Marquette A, Bechinger B
Biomolecules. 2018; 8(2).
PMID: 29670065
PMC: 6023007.
DOI: 10.3390/biom8020018.
Therapeutic effects of antimicrobial peptide on malignant ascites in a mouse model.
Xia L, Wu Y, Ma J, Zhang F
Mol Med Rep. 2018; 17(5):6245-6252.
PMID: 29512744
PMC: 5928604.
DOI: 10.3892/mmr.2018.8691.
Antitumor activity of HPA3P through RIPK3-dependent regulated necrotic cell death in colon cancer.
Cho E, Lee J, Park E, Seo C, Luchian T, Park Y
Oncotarget. 2018; 9(8):7902-7917.
PMID: 29487701
PMC: 5814268.
DOI: 10.18632/oncotarget.24083.